Pavadi Capital’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-58,331
Closed -$5.06M 15
2023
Q3
$5.06M Buy
+58,331
New +$5.27M 6.6% 7
2023
Q2
Sell
-79,800
Closed -$6.02M 16
2023
Q1
$6.02M Buy
79,800
+772
+1% +$58.2K 6.58% 9
2022
Q4
$6.07M Sell
79,028
-43,395
-35% -$3.3M 5.73% 7
2022
Q3
$8.16M Sell
122,423
-11,804
-9% -$748K 7.82% 2
2022
Q2
$7.02M Buy
134,227
+21,374
+19% +$1.21M 6.36% 3
2022
Q1
$6.4M Sell
112,853
-10,457
-8% -$560K 5.64% 4
2021
Q4
$6.35M Buy
+123,310
New +$6.05M 4.82% 7

Other funds holding CAH

Pavadi Capital's CAH Position: Q4 2023 in Review

Pavadi Capital sold out of Cardinal Health (CAH) in Q4 2023, closing a stake of 58,331 shares — an estimated $5.06M sold.

Pavadi Capital first reported a position in CAH in Q4 2021 and held it in 7 quarters. The position peaked at $8.16M in Q3 2022. 1,038 funds tracked by Wall St. Rank hold CAH as of Q4 2023.

  • Pavadi Capital reported no remaining Cardinal Health position as of Q4 2023 after selling out during the quarter.
  • Pavadi Capital sold 58,331 Cardinal Health shares in Q4 2023, an estimated $5.06M.
  • Pavadi Capital first reported a position in Cardinal Health in Q4 2021 and held it in 7 quarters.
  • Pavadi Capital's Cardinal Health position peaked at $8.16M in Q3 2022.
  • 1,038 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2023.

Based on Pavadi Capital's 13F filing for Q4 2023, filed 14 Feb 2024.